Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
Introduction
00:00 • 4min
The Rise of Radiotherapeutics in Oncology
03:41 • 3min
The Rise of Skepticism in Oncology
06:57 • 5min
TIA's Offer to Buy a Company for Less Than Cash
11:43 • 2min
Should the Boards Reject Below Cash Bids?
13:20 • 4min
The Impact of the Justice Department and SEC on Short Sellers on Biotech Stocks
17:06 • 3min
ASCO's Biotech TV Launch
20:09 • 4min
How to Launch a Business That Fulfills an Unmet Need
23:56 • 2min
The Future of Biotech
26:05 • 3min
The Impact of the ASCO Abstract Drops on Stocks
28:37 • 2min
Gilead's 21 Billion for Chordelvie
30:43 • 5min
The Challenges of Having a Good Active Drug
35:38 • 2min
The Role of CD40 in Immunology Targeted Therapies
37:54 • 5min
Sorepta's FDA Update
43:24 • 1min
The Kepler-Sen Challenges
44:41 • 3min
Accelerated Approvals: A Dilemma
47:50 • 4min
The Importance of Regulation Flexibility in Europe
52:16 • 4min
Biotech TV Launch
56:01 • 3min